Serological reactivity was analysed in plasma from 436 individuals with a history of disease compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS-CoV-2 infection. Over 99% of laboratory-confirmed cases developed a measurable antibody response (254/256) and 88% harboured neutralising antibodies (226/256). Antibody levels declined over 3 months following diagnosis, emphasising the importance of the timing of convalescent plasma collections. Binding antibody measurements can inform selection of convalescent plasma donors with high neutralising antibody levels.
All Keywords
【저자키워드】 convalescent plasma, SARS-CoV-2, Antibody Response, Neutralising Antibodies, symptomatic infection, high titre, 【초록키워드】 antibody, SARS-COV-2 infection, Diagnosis, neutralising antibody, plasma, disease, antibody level, Donor, individual, laboratory-confirmed, over, analysed, reactivity, declined, high neutralising antibody, the timing, with COVID-19, 【제목키워드】 Treatment, plasma, England, Donor, Analysis,
【저자키워드】 convalescent plasma, SARS-CoV-2, Antibody Response, Neutralising Antibodies, symptomatic infection, high titre, 【초록키워드】 antibody, SARS-COV-2 infection, Diagnosis, neutralising antibody, plasma, disease, antibody level, Donor, individual, laboratory-confirmed, over, analysed, reactivity, declined, high neutralising antibody, the timing, with COVID-19, 【제목키워드】 Treatment, plasma, England, Donor, Analysis,